Sapphiros Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Sapphiros focuses on developing diagnostic tests by integrating rigorous scientific work, thoughtful design, and scalable platforms to broaden accessibility. The company is based in Boston, Massachusetts, placing it in the U.S. biotechnology research scene. In 2021, Sapphiros UK Ltd completed an acquisition of Biocrucible Ltd, a UK-based firm specializing in molecular diagnostics, extending the group's capabilities into point-of-care testing. This corporate development aligns Sapphiros to serve customers seeking timely and reliable diagnostic results across clinical settings. With a mid-sized footprint, the company operates with a scalable approach intended to broaden access to diagnostic testing.